A select committee of British Members of Parliament have criticised Team Sky and Sir Bradley Wiggins, saying in a report released on Monday (5th March) they "crossed an ethical line" by using drugs allowed under anti-doping rules to enhance performance rather than treat medical issues.
Sir Bradley Wiggins used a banned powerful corticosteroid to enhance his performance while preparing to win the Tour de France in 2012, a British parliamentary committee said in a doping investigation report which accuses Team Sky of crossing an "ethical line" after preaching zero tolerance.
The legislators said they received evidence which shows Team Sky sought a therapeutic use exemption (TUE) for Wiggins to take triamcinolone "not to treat medical need" - asthma - "but to improve his power to weight ratio."
"We believe this powerful corticosteroid was being used to prepare Bradley Wiggins, and possibly other riders supporting him, for the (2012) Tour de France," the House of Commons select committee said in the report published Monday.
"He benefited from the performance-enhancing properties of this drug during the race."
In a statement, Wiggins denied "any drug was used without medical need."
Team Sky defended its reputation in a statement criticising "the anonymous and potentially malicious claim" by members of parliament.
But the report from a committee established in 2015 to investigate doping casts doubt on the team's use of medication and failure to keep accurate medical records.
Team Sky general manager "(Sir) David Brailsford must take responsibility for these failures, the regime under which Team Sky riders trained and competed and the damaging scepticism about the legitimacy of his team's performance and accomplishments," the report stated.